Dottorato in Medicina Molecolare

Marta Coscia, Francesca Pantaleoni, Chiara Riganti, Candida Vitale, Micol Rigoni, Silvia Peola, Barbara Castella, Myriam Foglietta, Valentina Griggio, Daniela Drandi, Marco Ladetto, Amalia Bosia, Mario Boccadoro, and Massimo Massaia “IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells” Leukemia. 2011 May;25(5):828-37

 

1) Coscia M, Capello M, Griggio V, Linty F, Vitale C, Peola S, Castella B, Rigoni M, Drandi D, Ruggeri M, Omedè P, Ladetto M, Novelli F, Boccadoro M, Massaia M. Identification by Serological Proteome Analysis (SERPA) of Tumor-Associated Antigens Eliciting Antibody Responses In Chronic Lymphocytic Leukemia (CLL). Blood (ASH Annual Meeting Abstract, Oral presentation), Nov 2010; 116: 917.

2) Coscia M, Rigoni M, Riganti C, Campia I, Vitale C, Griggio V, Peola S, Castella B, Sciancalepore P, Drandi D, Ladetto M, Bosia A, Boccadoro M, Massaia M. The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells. Blood (ASH Annual Meeting Abstracts, Oral Presentation), Nov 2011; 118: 735.

3) Coscia M.1,2, Rigoni M.2 , Riganti C.3, Campia I.3, Vitale C.1,2 , Griggio V.2, Peola S.2, Castella B.2, Pantaleoni F.2, Sciancalepore P.1,2, Drandi D.1, Omede’ P.1, Ladetto M.1, Bosia A.3, Boccadoro M.1 and Massaia M.1,2 “Accelerated activity of the mevalonate pathway supports the immune escape and multidrugresistance phenotype of IGHV unmutated CLL cells” IWCLL Houston 28-30 ottobre 2011

4) M. Coscia, V. Griggio, M. Capello, C. Vitale, F. Linty, S. Peola, P. Cappello, B. Castella, M. Rigoni, P. Sciancalepore, D. Drandi, M. Ruggeri, P. Omedè, M. Ladetto, F. Novelli, M. Boccadoro, M. Massaia. "Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia" Clinical Lymphoma, Myeloma & Leukemia 2011 Oct; 11(s2):s176-s177. Fourteen International Workshop on Chronic Lymphocytic Leukemia, October 28-30, 2011, Houston, TX

5) Rigoni M.2 ,Coscia M.1,2, Riganti C.3, Campia I.3, Vitale C.1,2 , Peola S.2, Castella B.2, Griggio V.2, Pantaleoni F.2, Sciancalepore P.1,2, Drandi D.1, Ladetto M.1, Bosia A.3, Boccadoro M.1 and Massaia M.1,2  “Targeting the Mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells” 43°Congress of the Italian Society of Hematology, Napoli, Italy; October 16-19, 2011 Hematologica 2011

6) Griggio V, Capello M, Linty F, Vitale C, Peola S, Cappello P, Castella B, Rigoni M,  Sciancalepore P, Drandi D, Ruggeri M, Omedè P, Ladetto M, Novelli F, Boccadoro M, Massaia M, Coscia M. “Identification by seroloigcal proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia” 43°Congress of the Italian Society of Hematology, Napoli, Italy; October 16-19, 2011 Hematologica 2011

7) Marta Coscia, Valentina Griggio, Michela Capello, Federica Linty, Candida Vitale, Silvia Peola, Barbara Castella, Micol Rigoni, Daniela Drandi, Marina Ruggeri, Paola Omedé, Marco Ladetto, Franco Novelli, Mario Boccadoro, Massimo Massaia. Serological proteome analysis (SERPA) for the identification of novel tumor-associated antigens in chronic lymphocytic leukemia. Ann Oncol (2011) 22(suppl: iv143-iv147 doi:10.1093/annonc/mdr214.  11th International Conference on Malignant Lymphoma 15-18 June 2011, Lugano (Switzerland)

8)M. Coscia, V. Griggio, M. Capello, F. Linty, C. Vitale, S. Peola, P. Cappello, B. Castella, M. Rigoni, P. Sciancalepore, D. Drandi, M. Ruggeri, P. Omedè, M. Ladetto, F. Novelli, M. Boccadoro and M. Massaia. Serological proteome analysis (SERPA) for the identification of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia. Haematologica (in Press).   16th Congress of the European Hematology Association 6-9 June 2011, London (United Kingdom).

9)Marta Coscia, Francesca Pantaleoni, Chiara Riganti, Candida Vitale, Micol   Rigoni, Silvia Peola, Daniela Drandi, Marco Ladetto, Marina Ruggeri, Valentina Griggio, Barbara Castella, Patrizia Sciancalepore, Paola Omedè, Amalia Bosia, Mario Boccadoro and Massimo Massaia. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and depend from the anti-apoptotic effect of environmental signals. Haematologica (in Press). 16th Congress of the European Hematology Association 6-9 June 2011, London (United Kingdom)

10)Marta Coscia, Micol Rigoni, Chiara Riganti, Ivana Campia, Candida Vitale, Silvia Peola, Barbara Castella, Valentina Griggio, Francesca Pantaleoni, Patrizia Sciancalepore, Daniela Drandi, Marco Ladetto, Amalia Bosia, Mario Boccadoro and Massimo Massaia. Impact of the mevalonate pathway and Hif/Pgp axis in microenvironment-mediated modulation of multidrug-resistance in CLL cells. Haematologica (in Press). 16th Congress of the European Hematology Association 6-9 June 2011, London (United Kingdom).

11)Coscia M, Pantaleoni F, Riganti C, Rigoni M, Peola S, Vitale C, Drandi D,   Ladetto M, Bosia A, Boccadoro M, Massaia M. “The local microenvironment plays a different role in the survival of tumor cells in chronic lymphocytic leukemia with mutated and unmutated immunoglobulin (IG) vh genes.” Haematologica, vol.2009/s2 ISSN: 0390-6078

12)Pantaleoni F, Coscia M, Bussolati B, Deambrosis I, Peola S, Rigoni M, Boccadoro M, Camussi G, Massaia M. "Immunoglobulin Variable Heavy-Chain (Ig VH) Mutational Status And Tumor Microenvironment Interactions In B-Cell Chronic Lymphocytic Leukaemia (CLL)". Leukemia & Lymphoma, Sept 2007; 48 (suppl 1):S143.

 

Seminario: “European Working conference on the effects of aminobisphosphonate on angiogenesis and immunomodulation.” (Cervo, Imperia 6-8 Ottobre 2005)    

 

Riunione di lavoro su “Gamma/delta T cells as effectors of immune responses in neoplastic disease: mechanism of activity and clinical applications” (organizzato dalla Divisione Universitaria di Ematologia, via Genova 3: Torino 18 dicembre 2006)

 

Corso su “La sicurezza nel laboratorio di analisi” Workshop Teorico Pratico (organizzato da PBI International). (Milano, 25 settembre 2007)

 

Corso su “La cabina di sicurezza biologica. La buona pratica di conduzione e gestione” Workshop Teorico Pratico (organizzato da PBI International.) (Milano, 25 settembre 2007)

 

Seminario “3rd Cervo Preclinical Working conference- The mevalonate pathway as a target of therapeutic intervention and immune modulation in cancer and infections” (Cervo, Imperia 4-6 Ottobre 2007)

 

Seminario SIES “Discutiamone insieme” “Leucemie PH+ :genoma,protein e meccanismi di resistenza alla targeted therapy” “Dalla biologia ai nuovi farmaci nel Mieloma Multiplo” (Firenze, 11 giugno 2009)

 

Seminario “4^th Cervo Preclinical Working Conference (CPWC)- Antitumor Activity of Aminobisphosphonates: from Benches, to the Bedside, and Back”  (Cervo,Imperia 1-3 ottobre 2009)

 

1°Convegno Regionale “Nuove frontiere in Medicina: la Medicina di Genere in cardiologia, Farmacologia, Oncologia, Endocrinologia, Pneumologia, Immunologia”  (Torino, 26 Gennaio 2011 Centro Congressi e Convegni “MOLINETTE INCONTRA”)

 

Partecipazione a congressi come relatrice

43°Congress of the Italian Society of Hematology, Napoli, Italy; October 16-19, 2011 Hematologica 2011^“Targeting the Mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells”

 

Ethan M Shevach, M.D. "Foxp3+ T Regulatory Cells: What do they really do?"

"D-Day" Scuola di Dottorato in Scienze della Vita e della Salute

Dr. Massimiliano Galdiero "Entry mechanism of Herpes Simplex Virus Type 1"

Dr. Cavallaro Ugo "Adhesion molecules and growth factor receptors: a novel 
partnership that links receptor trafficking with cancer progression"

Dr. Leporatti "Nanotechnology for Cancer therapy: Nanocarriers and biomechanism"

Dr Chrstian Ottensmeier "Dna vaccination from the lab to the clonic. The Southhampton
experience"

Prof. Garzino Demo "A nove mechanism to inhibit HIV infection mediated by the chemokine
receptor CCR6"